Dandelion Health, founded in 2020 and based in the United States, operates at the intersection of clinical AI and medical data infrastructure. The company provides AI developers, life sciences companies, and healthcare organizations with access to multimodal real-world patient data for building and evaluating clinical AI products. Its founding team brings expertise from health tech, hospital systems, academia, and clinical AI.
The company's core offering is its Digital Biobank for Clinical AI Development, described as a comprehensive digital biobank that aggregates de-identified clinical data from multiple U.S. health systems. The dataset covers over 10 million patients, with records dating back to 2016. This resource is designed to support the creation and validation of clinical AI algorithms.
Beyond data provision, Dandelion Health operates a Clinical AI Marketplace that connects algorithm developers with life sciences companies involved in drug development and clinical research. It also runs the American Heart Association AI Assessment Lab, which delivers independent, scientifically rigorous evaluations of cardiology and other clinical AI algorithms using real-world performance data. The company's work spans the healthcare, life sciences, clinical research, and pharmaceutical sectors.
